Healthcare Sales & Marketing Network News: Testosterone

Searching News Database: Testosterone

HSMN NewsFeed - 13 Apr 2022
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
Biopharmaceuticals Drug Delivery Mergers & Acquisitions

HSMN NewsFeed - 13 Jan 2022
PANTHERx Rare(R) Selected by Xeris Pharmaceuticals to Distribute Recorlev(R) (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients with Cushing's Syndrome
Biopharmaceuticals Distribution

HSMN NewsFeed - 14 Jun 2021
FDA Clears LPCN 1154 IND Application for a Phase 2 Postpartum Depression Study
Biopharmaceuticals FDA

HSMN NewsFeed - 4 May 2021
Astellas' XTANDI(TM) (enzalutamide) Approved by European Commission for Men with Metastatic Hormone-Sensitive Prostate Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Nov 2020
XTANDI(R) (enzalutamide soft capsules) Approved by China NMPA for the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 29 May 2020
XTANDI(R) (enzalutamide) Approved by Japan MHLW for the Treatment of Prostate Cancer with Distant Metastasis
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 24 Feb 2020
Lipocine Announces Regulatory Path Forward for TLANDO(TM) Resubmission
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Nov 2019
Lipocine Receives Complete Response Letter for TLANDO(TM) from U.S. FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Aug 2019
Lipocine Announces Trial Date in Lipocine's Infringement Lawsuit Against Clarus Therapeutics and Will Seek a Permanent Injunction
Biopharmaceuticals Litigation

HSMN NewsFeed - 30 Jul 2019
Acerus And Aytu Bioscience To Co-Promote NATESTO(R) In The United States
Biopharmaceuticals Licensing

HSMN NewsFeed - 23 Jul 2019
Lipocine Receives FDA Clearance for Clinical Testing its NASH Candidate, LPCN 1144, in Expanded Target Population
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Jul 2019
ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 29 Apr 2019
U.S. FDA Accepts New Drug Application and Grants Priority Review for Darolutamide
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Feb 2019
Lipocine Inc. Announces FDA Clearance of IND to Commence Phase 2 Study of LPCN 1144 in Biopsy Confirmed NASH Subjects
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Feb 2018
ZYTIGA(R) (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 18 Dec 2017
Aytu BioScience Announces Appointment of David Green as Chief Financial Officer
Biopharmaceuticals Urology Personnel

HSMN NewsFeed - 1 Dec 2017
TesoRx Pharma And ASKA Pharmaceutical Expand Territory And Scope Of Partnering Agreement For TesoRx's Oral Testosterone Product
Biopharmaceuticals Distribution

HSMN NewsFeed - 26 Oct 2017
Aytu BioScience Provides Quarterly Update on the Natesto(R) U.S. Launch
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 11 Oct 2017
Janssen Submits New Drug Application to U.S. FDA for Apalutamide (ARN-509) to Treat Men with Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 3 Oct 2017
Aytu BioScience Announces International Distribution Agreement for Fiera(R) in Japan
Biopharmaceuticals Urology Distribution

HSMN NewsFeed - 20 Jul 2017
Churchill Pharmaceuticals Announces NDA Filing Acceptance for YONSA(TM) by the U.S. FDA
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 13 Jul 2017
Aytu BioScience Expands MiOXSYS(R) Distribution Network with a Fertility-Focused Company in Over 20 Countries in Europe
Diagnostics Urology Distribution

HSMN NewsFeed - 12 Jul 2017
Viking Therapeutics Completes Enrollment in Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture
Biopharmaceuticals Orthopaedic

HSMN NewsFeed - 1 Mar 2017
Perrigo Announces FDA Final Approval For The Generic Version Of Axiron(R) Topical Solution, 30 mg/1.5 mL
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 15 Feb 2017
Lipocine Announces the Promotion of Gregory Bass to Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 27 Jan 2017
Foresee Pharmaceuticals Announces Top-Line Results from Phase 3 Registration Study in Advanced Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Jan 2017
Myovant Sciences Initiates Phase 3 Clinical Program of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Biopharmaceuticals

HSMN NewsFeed - 8 Nov 2016
Innovus Pharma Signs Exclusive License and Distribution Agreement with Elis Pharmaceuticals for Zestra(R) in Lebanon
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 31 Oct 2016
Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2016
OPKO Health to Acquire Transition Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Jan 2016
Antares Pharma Announces CEO Transition
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Dec 2015
Acerus Announces Termination of NATESTO(TM) Agreement with Endo
Biopharmaceuticals Distribution

HSMN NewsFeed - 14 Dec 2015
Antares Pharma Announces FDA Approval of Sumatriptan Injection USP
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Oct 2015
GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence
Biopharmaceuticals Urology FDA

HSMN NewsFeed - 12 Oct 2015
Teva Announces Exclusive Launch of Generic Avodart(R) Capsules in the United States
Biopharmaceuticals Urology Generics Product Launch

HSMN NewsFeed - 14 Jul 2015
Antares Pharma Appoints Peter J. Graham, Esq., Senior Vice President, General Counsel, Human Resources, Chief Compliance Officer and Corporate Secretary
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 May 2015
Debiopharm International SA Announces Phase III Positive Results for Triptorelin 6-month Formulation in the Management of Central Precocious Puberty (CPP)
Biopharmaceuticals

HSMN NewsFeed - 18 Nov 2014
Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Oct 2014
Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 15 Sep 2014
Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Aug 2014
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Aug 2014
TesoRx Closes $10M in Funding, Secures Key Patent and Hires Renowned Urologist as Chief Medical Officer
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 12 Jun 2014
Clarus Therapeutics Secures $31.5 Million in Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 21 May 2014
Clarus Therapeutics Appoints Patrick Shea Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Apr 2014
Auxilium and Sobi Announce Encore Presentation of XIAFLEX/Xiapex Data at European Association of Urology Congress
Biopharmaceuticals Urology

HSMN NewsFeed - 17 Mar 2014
Clarus Therapeutics Appoints John Gargiulo Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Mar 2014
U.S. FDA Approves AVEED(TM) (Testosterone Undecanoate) Injectable Testosterone Replacement Therapy For Men Living With Hypogonadism, Or Low-T
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Feb 2014
Ipsen announces positive top line results from phase III clinical study of Decapeptyl(R) (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with prostate cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Jan 2014
Antares Pharma Announces Availability of OTREXUP (Methotrexate) Injection for Subcutaneous Use to Treat Rheumatoid Arthritis (RA) and Psoriasis in Adults, and Polyarticular Idiopathic Arthritis (pJIA) in Children
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 7 Jan 2014
Lipocine Announces New Appointments to Its Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 13 Dec 2013
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome Study of Collagenase Clostridium Histolyticum
Biopharmaceuticals Orthopaedic

HSMN NewsFeed - 6 Dec 2013
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(R) for the Treatment of Peyronie's Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Nov 2013
Auxilium Pharmaceuticals Presented New Analyses of XIAFLEX(R) Peyronie's Disease Data at SMSNA Scientific Meeting
Biopharmaceuticals Urology

HSMN NewsFeed - 19 Nov 2013
Antares Pharma Appoints David H. Bergstrom Ph.D. as Senior Vice President Pharmaceutical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Nov 2013
Auxilium Announces Results of the XIAFLEX(R) in Dupuytren's MULTICORD Contracture Trial
Biopharmaceuticals

HSMN NewsFeed - 11 Oct 2013
Auxilium Pharmaceuticals, Inc. Announces License Agreement For The Marketing Rights To STENDRA(TM) In The United States And Canada
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Oct 2013
Auxilium Pharmaceuticals, Inc. Presented Data At The ASSH Annual Meeting About XIAFLEX(R) For The Treatment Of Dupuytren's Contracture
Biopharmaceuticals Othopaedic

HSMN NewsFeed - 28 Aug 2013
Auxilium Receives Notification of XIAFLEX(R) PDUFA Extension
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jul 2013
BioSante Hires VP of New Business Development and Contract Manufacturing and Announces New Appointment to Board of Directors
Biopharmaceuticals Generics Personnel

HSMN NewsFeed - 7 Jan 2013
Auxilium Pharmaceuticals, Inc. Announces Expansion of Its Exclusive License for XIAFLEX(R) (CCH) to Include the Potential Treatment of Cellulite as an Additional Indication
Biopharmaceuticals

HSMN NewsFeed - 27 Dec 2012
U.S. Food and Drug Administration Accepts XIAFLEX(R) Supplemental Biologics License Application Filing for the Treatment of Peyronie's Disease
Biopharmaceuticals Urology

HSMN NewsFeed - 19 Nov 2012
ZYTIGA(R) Receives Positive Regulatory Recommendation in the European Union for Treatment of Metastatic Castration-Resistant Prostate Cancer before Chemotherapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 4 Oct 2012
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Sep 2012
Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX(R) Safety Update
Biopharmaceuticals

HSMN NewsFeed - 24 Jul 2012
Debiopharm Group(TM) - First Patient Treated in Phase III Study With Subcutaneous Administration of Debio 8206 for Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 Jun 2012
Clarus Therapeutics Appoints Bela S. Denes, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jun 2012
Tokai Pharmaceuticals� Galeterone Receives Fast Track Designation from the FDA for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 21 May 2012
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim(R) in the U.S.
Biopharmaceuticals Urology

HSMN NewsFeed - 28 Feb 2012
FIRMAGON(R) (degarelix) demonstrates non-inferiority to goserelin with bicalutamide in reducing prostate volume in prostate cancer patients while providing better relief from lower urinary tract symptoms
Biopharmaceuticals Urology Oncology

HSMN NewsFeed - 23 Feb 2012
Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX(R) in Canada, Australia, Brazil and Mexico
Biopharmaceuticals

HSMN NewsFeed - 15 Feb 2012
BioSante Pharmaceuticals Announces FDA Approval for Bio-T-Gel�
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Feb 2012
Auxilium Announces Appointments to Enhance Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Dec 2011
Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer and President
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Dec 2011
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA

HSMN NewsFeed - 1 Dec 2011
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX(R) Study for Frozen Shoulder Syndrome
Biopharmaceuticals

HSMN NewsFeed - 7 Sep 2011
Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX(R) Multi-Cord Study
Biopharmaceuticals

HSMN NewsFeed - 6 Sep 2011
Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX(R) Safety Update
Biopharmaceuticals

HSMN NewsFeed - 8 Aug 2011
Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Aug 2011
Antares Pharma Announces Positive Study Results with VIBEX(TM) MTX in Rheumatoid Arthritis Patients
Biopharmaceuticals Devices Drug Delivery

HSMN NewsFeed - 18 Jul 2011
BioSante Pharmaceuticals Announces Management Team Additions
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jul 2011
Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product (Anturol(R))
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Jun 2011
Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot(R) (leuprolide acetate for depot suspension) for the Palliative Treatment of Advanced Prostate Cancer
Biopharmaceuticals Drug Delivery Oncology FDA

HSMN NewsFeed - 10 May 2011
Columbia Laboratories Appoints Kip Martin as Vice President, Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Apr 2011
Auxilium Pharmaceuticals, Inc. Announces Launch of XIAPEX(R) in EU by Pfizer
Biopharmaceuticals

HSMN NewsFeed - 8 Apr 2011
Antares Pharma Announces FDA Acceptance of Anturol(R) NDA for Filing
Biopharmaceuticals Urology

HSMN NewsFeed - 9 Mar 2011
Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX(R) Phase III Double-Blind Studies for Peyronie's Disease
Biopharmaceuticals

HSMN NewsFeed - 14 Feb 2011
BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data in Phase III Program
Biopharmaceuticals

HSMN NewsFeed - 6 Dec 2010
XIAFLEX(R) Effective in Nonsurgically Treating MP and PIP Joints with Dupuytren's Contractures in Second Pivotal Study
Biopharmaceuticals

HSMN NewsFeed - 5 May 2010
Frank C. Condella, Jr. Appointed President and Chief Executive Officer of Columbia Laboratories
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Mar 2010
Auxilium Announces Promotion of Benjamin Del Tito Jr., Ph.D. to Executive Vice President, Regulatory Affairs and Project Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Mar 2010
Auxilium Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 4 Mar 2010
Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 2 Mar 2010
Antares Pharma Announces Completion of Patient Enrollment in Phase 3 Pivotal Trial of Anturol for the Treatment of Overactive Bladder
Biopharmaceuticals Urology Drug Delivery

HSMN NewsFeed - 9 Feb 2010
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Feb 2010
Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Feb 2010
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Jan 2010
Pfizer and Auxilium Announce Commencement of European Regulatory Review of XIAFLEXTM for the Treatment of Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 20 Jan 2010
Antares Pharma Expands Executive Team and Appoints Pavan Handa as Senior Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Dec 2009
Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Nov 2009
Ipsen's Decapeptyl(R) 6-Month Formulation Receives Marketing Authorization in France for the Treatment of Locally Advanced or Metastatic Prostate Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 19 Oct 2009
Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Sep 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Votes Unanimously 12-0 to Recommend Approval of XIAFLEX(TM) for Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 17 Aug 2009
AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology

HSMN NewsFeed - 4 Aug 2009
Ferring Pharmaceuticals Announces Trade Name FIRMAGON(R) (degarelix for injection) for Advanced Prostate Cancer Treatment
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 31 Jul 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Confirms Date to Review XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Jul 2009
Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations
Biopharmaceuticals Regulatory

HSMN NewsFeed - 14 Jul 2009
Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
Biopharmaceuticals Urology Oncology FDA

HSMN NewsFeed - 30 Jun 2009
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 23 Jun 2009
Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries
Biopharmaceuticals

HSMN NewsFeed - 18 Jun 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Sets Tentative Date to Review XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals FDA

HSMN NewsFeed - 8 May 2009
Tokai Pharmaceuticals Closes $22 Million Series D Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Apr 2009
XIAFLEX(TM) for the Treatment of Dupuytren's Contracture Receives Priority Review From the U.S. Food and Drug Administration
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Apr 2009
Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show
Biopharmaceuticals

HSMN NewsFeed - 27 Apr 2009
First Ever Prospective Fracture Study in Prostate Cancer Patients on ADT Reveals These Men Are at High Risk for Skeletal Fractures
Biopharmaceuticals Oncology Urology

HSMN NewsFeed - 14 Apr 2009
BioSante Announces Launch of Elestrin in the U.S.
Biopharmaceuticals

HSMN NewsFeed - 18 Mar 2009
FIRMAGON(R) (Degarelix) is Launched in Europe for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Mar 2009
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Mar 2009
AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Licensing Urology

HSMN NewsFeed - 4 Mar 2009
Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Feb 2009
European Commisssion Grants Ferring Pharmaceuticals Approval of FIRMAGON(R) (Degarelix) for Treatment of Prostate Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 2 Feb 2009
Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 2 Feb 2009
Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 28 Jan 2009
VIVUS Announces Senior Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jan 2009
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Dec 2008
Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc to Acquire U.S. Rights to Elestrin (TM)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 7 Aug 2008
BioSante Pharmaceuticals Announces Reacquisition of Elestrin(TM), FDA Approved for Treatment of Hot Flashes
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 8 Jul 2008
Agile Therapeutics Appoints Senior Executive Jeffrey Frick as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2008
Indevus Receives Approvable Letter from FDA for NEBIDO(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jun 2008
FDA Approves GlaxoSmithKline's AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
Biopharmaceuticals Urology FDA

HSMN NewsFeed - 4 Jun 2008
Indevus Pharmaceuticals Provides Update on NEBIDO(R) NDA Status
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Jun 2008
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 21 May 2008
Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
Biopharmaceuticals Urology

HSMN NewsFeed - 15 May 2008
Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations
Biopharmaceuticals Licensing

HSMN NewsFeed - 30 Apr 2008
FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(R) DEPOT and TRELSTAR(R) LA
Biopharmaceuticals Devices Drug Delivery Oncology FDA

HSMN NewsFeed - 23 Apr 2008
MacroChem Acquires Virium Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 21 Apr 2008
VIVUS Appoints Charles J. Casamento to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Apr 2008
BioSante Pharmaceuticals Appoints Michael C. Snabes, M.D., PhD, Vice President, Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Apr 2008
VIVUS Enters into $30 Million Funding Collaboration for the Phase 3 Studies of Avanafil for Erectile Dysfunction
Biopharmaceuticals

HSMN NewsFeed - 27 Mar 2008
Positive Phase III Data Unveiled for New GnRH Blocker Degarelix
Biopharmaceuticals Urology

HSMN NewsFeed - 26 Mar 2008
Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Biopharmaceuticals Urology

HSMN NewsFeed - 19 Mar 2008
BioSante Pharmaceuticals Initiates Third LibiGel(R) Phase III Trial in the Treatment of Female Sexual Dysfunction under an SPA
Biopharmaceuticals

HSMN NewsFeed - 19 Mar 2008
New Study Backs use of Gene-Based Urine Test in Prostate Cancer
Diagnostics Oncology Urology

HSMN NewsFeed - 25 Feb 2008
GTx's Toremifene Citrate 80 mg Meets Primary and Key Endpoints in Phase III Trial in Advanced Prostate Cancer Patients on Androgen Deprivation Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Feb 2008
Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation in Advanced Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Feb 2008
Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Jan 2008
BioSante Pharmaceuticals Announces FDA Special Protocol Assessment (SPA) for LibiGel(R) in FSD
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jan 2008
Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
Biopharmaceuticals

HSMN NewsFeed - 18 Jan 2008
Enlarged Prostate Treatment Study Shows Combination of AVODART(R) and Tamsulosin Provides Greater Benefit Than Either Medication Alone
Biopharmaceuticals Urology

HSMN NewsFeed - 7 Jan 2008
BioSante Pharmaceuticals Announces Initiation of LibiGel(R) (Transdermal Testosterone Gel) Phase III Safety Study
Biopharmaceuticals

HSMN NewsFeed - 20 Dec 2007
Marketing of Viadur(R) (leuprolide acetate implant) to Phase Out by April 2008
Biopharmaceuticals

HSMN NewsFeed - 17 Dec 2007
Auxilium Pharmaceuticals, Inc. Completes Enrollment in Two Phase III Clinical Trials of XIAFLEX(TM) for Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 27 Nov 2007
Clarus Therapeutics Announces Completion of $8 Million Series C Financing Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Nov 2007
VIVUS Initiates Second Qnexa Pivotal Phase 3 Trial in Obese Patients
Biopharmaceuticals

HSMN NewsFeed - 1 Nov 2007
FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 23 Oct 2007
Bentley Pharmaceuticals, Inc. Announces Plans to Separate Its Two Businesses and Explore Strategic Alternatives with Respect to Its Generics Business
Biopharmaceuticals

HSMN NewsFeed - 15 Oct 2007
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
Biopharmaceuticals Licensing

HSMN NewsFeed - 27 Sep 2007
Columbia Laboratories Signs U.S. License and Supply Agreement with Ascend Therapeutics to Market PROCHIEVE(R) 4% Progesterone Gel
Biopharmaceuticals Licensing

HSMN NewsFeed - 11 Sep 2007
BioSante Pharmaceuticals Announces FDA Clarity on Development of LibiGel(R) (Transdermal Testosterone Gel) in the Treatment of Female Sexual Dysfunction
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Sep 2007
Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX(TM) U.S. Pivotal Phase III Study
Biopharmaceuticals

HSMN NewsFeed - 5 Sep 2007
BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Sep 2007
Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
Biopharmaceuticals Urology

HSMN NewsFeed - 31 Aug 2007
Eligard(R) six-month formulation successfully completes European approval procedure
Biopharmaceuticals Drug Delivery Regulatory Oncology

HSMN NewsFeed - 28 Aug 2007
Indevus Announces Submission of New Drug Application
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 16 Aug 2007
Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Aug 2007
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
Biopharmaceuticals

HSMN NewsFeed - 30 Jul 2007
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 30 Jul 2007
VIVUS Receives FDA Approval of Evamist NDA
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 25 Jul 2007
Repros Reports That Patients Exposed to Proellex For Up To Six Months Demonstrated A Benign Endometrium Based On Biopsy
Biopharmaceuticals

HSMN NewsFeed - 24 Jul 2007
The Journal of Hand Surgery Publishes Initial Phase III Data on XIAFLEX(TM) (formerly known as AA4500), Auxilium's Investigational Treatment for Patients with Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 11 Jul 2007
Dr. William E. Cochran Joins arGentis Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jul 2007
Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 Jun 2007
VIVUS Completes End of Phase 2 Meeting with the FDA for Qnexa, a Treatment for Obesity
Biopharmaceuticals

HSMN NewsFeed - 21 Jun 2007
New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
Biopharmaceuticals Cardiology

HSMN NewsFeed - 13 Jun 2007
BioSante Pharmaceuticals Announces the Commercial Launch of Elestrin(TM)
Biopharmaceuticals

HSMN NewsFeed - 12 Jun 2007
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
Biopharmaceuticals

HSMN NewsFeed - 7 Jun 2007
Indevus Reports Positive Data From Phase III NEBIDO(R) Trial
Biopharmaceuticals

HSMN NewsFeed - 23 May 2007
Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at Annual Meeting of American Urological Association
Biopharmaceuticals Urology

HSMN NewsFeed - 22 May 2007
Auxilium Announces New Data That Show Total Testosterone Blood Levels Increase Significantly Following Switch from AndroGel(R) to Testim(R)
Biopharmaceuticals

HSMN NewsFeed - 16 May 2007
KV Pharmaceutical Company Completes Acquisition of U.S. Rights to EvaMist(TM)
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 16 May 2007
VIVUS Closes EvaMist Transaction with KV Pharmaceutical
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 16 May 2007
CollaGenex Pharmaceuticals and QuatRx Pharmaceuticals Announce Agreement for the Development and Commercialization of Becocalcidiol
Biopharmaceuticals Dermatology Licensing

HSMN NewsFeed - 7 May 2007
BioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei Bioscience
Biopharmaceuticals Licensing

HSMN NewsFeed - 19 Apr 2007
AEterna Zentaris Reports First Patients Treated with Cetrorelix for Phase 3 Program in BPH
Biopharmacetuicals Urology

HSMN NewsFeed - 30 Mar 2007
KV Pharmaceutical Company Acquires U.S. Rights to EvaMist(TM) - A Novel New Product for the Treatment of the Symptoms of Menopause
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 30 Mar 2007
VIVUS Agrees to Sell EvaMist Rights to KV Pharmaceutical
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 26 Mar 2007
Indevus Reports That Interim Review of NEBIDO(R) Phase III Data Indicates Trial Is Likely to Meet Primary Endpoints
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 23 Feb 2007
GTx's ACAPODENE Interim Bone Mineral Density and Lipid Data Highlighted at Press Briefing at Prostate Cancer Symposium of the American Society of Clinical Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Feb 2007
Auxilium Announces Results from Phase III Trial that Show AA4500 Successful in Treating Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 4 Feb 2007
Phase III Trial of Progesterone for the Prevention of Preterm Birth in Women with a Previous Preterm Birth Earlier than 35 Weeks Does Not Meet Endpoints
Biopharmaceuticals

HSMN NewsFeed - 8 Jan 2007
Neurocrine Biosciences Announces Positive Results From Second Phase II Study With Its Orally Active GnRH Receptor Antagonist in Endometriosis
Biopharmaceuticals

HSMN NewsFeed - 8 Jan 2007
AEterna Zentaris Initiates First Study of Phase 3 Program with Cetrorelix in BPH - 600 Patient Trial Conducted in the United States and Canada
Biopharmaceuticals Urology

HSMN NewsFeed - 2 Jan 2007
Antares ATD(TM) Formulation Enters Phase III Study
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 28 Dec 2006
BioSante Pharmaceuticals Initiates Phase III Study of LibiGel(R) (transdermal testosterone gel) in the Treatment of Female Sexual Dysfunction
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 20 Dec 2006
Repros' Androxal Shows Noninferiority in Interim Phase 3 Analysis
Biopharmaceuticals

HSMN NewsFeed - 18 Dec 2006
BioSante Pharmaceuticals Receives FDA Approval of Bio-E-Gel(R) (estradiol gel), to be Marketed as Elestrin(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Dec 2006
Repros Announces Appointment of Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Dec 2006
Repros Reports Proellex Achieves Statistically Significant Pain Reduction in Endometriosis Trial
Biopharmaceuticals

HSMN NewsFeed - 12 Dec 2006
VIVUS Announces FDA Acceptance of EvaMist(TM) NDA Submission
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Dec 2006
Paladin and Auxilium Sign Exclusive Distribution Agreement for Testim'R'
Biopharmaceuticals Distribution

HSMN NewsFeed - 12 Dec 2006
Auxilium Pharmaceuticals, Inc. Announces Distribution Agreement With Paladin Labs for Testim(R) in Canada
Biopharmaceuticals Distribution

HSMN NewsFeed - 8 Dec 2006
GTx Announces That Ostarine Achieved Primary Endpoint of Lean Body Mass and a Secondary Endpoint of Improved Functional Performance in a Phase II Clinical Trial and Reacquisition of Full Rights to GTx SARM Program
Biopharmaceuticals

HSMN NewsFeed - 7 Dec 2006
James Meer Appointed Chief Financial Officer of Columbia Laboratories
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Dec 2006
CutisPharma Completes Progesterone Vaginal Suppository Product Line
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 1 Dec 2006
Eligard(R) six-month formulation approved in Germany
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 22 Nov 2006
Cellegy Announces Stockholder Approval of Asset Sale to ProStrakan
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 20 Nov 2006
Auxilium Pharmaceuticals, Inc. Initiates Phase III Trials for AA4500 in Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 8 Nov 2006
BioSante Pharmaceuticals Signs Bio-E-Gel(R) Marketing Agreement With Bradley Pharmaceuticals, Inc.
Biopharmaceuticals

HSMN NewsFeed - 1 Nov 2006
VIVUS Appoints Changjin (CJ) Wang, Ph.D. as Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Oct 2006
Repros Reports Partial Interim Assessment of Phase 2 Study of Proellex(TM) in Endometriosis
Biopharmaceuticals

HSMN NewsFeed - 20 Oct 2006
Indevus Announces the Finalization of Supply Agreement with Schering AG, Germany for NEBIDO(R)
Biopharmaceuticals

HSMN NewsFeed - 18 Oct 2006
Auxilium Pharmaceuticals Announces R&D Portfolio Change
Biopharmaceuticals

HSMN NewsFeed - 12 Oct 2006
BioSante Pharmaceuticals Presents Bio-E-Gel(R) Woman-to-Partner Transfer Study at Menopause Society Meeting
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 3 Oct 2006
Spectrum Pharmaceuticals Announces Positive Phase 2 Data with Ozarelix in Patients with Benign Prostatic Hypertrophy
Biopharmaceuticals Urology

HSMN NewsFeed - 3 Oct 2006
AEterna Zentaris Announces Positive Phase 2 Results for Ozarelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology

HSMN NewsFeed - 26 Sep 2006
CutisPharma Launches 25 mg Strength in Progesterone Vaginal Suppository Product Line
Biopharmaceuticals

HSMN NewsFeed - 13 Sep 2006
Watson and Unimed Pharmaceuticals, Inc. Settle Lawsuit Over AndroGel(R) Testosterone Gel
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 13 Sep 2006
Unimed Pharmaceuticals, Inc. Settles AndroGel(R) Litigation with Watson Pharmaceuticals, Inc. and Paddock Laboratories/Par Pharmaceutical Companies, Inc.
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 13 Sep 2006
Par Pharmaceutical Announces Agreement With Unimed Pharmaceuticals to Settle AndroGel(R) Patent Litigation
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 5 Sep 2006
Auxilium Pharmaceuticals Announces New Strategic Initiatives
Biopharmaceuticals

HSMN NewsFeed - 5 Sep 2006
Oscient Pharmaceuticals and Auxilium Pharmaceuticals Agree to Conclude TESTIM(R) Co-Promotion Partnership
Biopharmaceuticals

HSMN NewsFeed - 21 Aug 2006
Oscient Pharmaceuticals Completes Acquisition of Cardiovascular Therapy ANTARA(R) 130mg (fenofibrate) Capsules
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 10 Aug 2006
Oscient Pharmaceuticals and Abbott Canada Enter into Commercialization Agreement for FACTIVE Tablets
Biopharmaceuticals

HSMN NewsFeed - 3 Aug 2006
AEterna Zentaris Enters a License and Collaboration Agreement for Ozarelix with Nippon Kayaku for the Japanese Market
Biopharmaceuticals Licensing

HSMN NewsFeed - 2 Aug 2006
Spectrum Pharmaceuticals Announces Phase 2 Data for Ozarelix in Hormone-Dependent Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Aug 2006
AEterna Zentaris Announces Positive Phase 2 Results for Ozarelix (D-63153) in Hormone-Dependent Inoperable Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Aug 2006
Columbia Laboratories Completes Enrollment in Pivotal Phase III Study of Prochieve 8% to Prevent Preterm Birth
Biopharmaceuticals

HSMN NewsFeed - 24 Jul 2006
Oscient Pharmaceuticals Agrees to Acquire Cardiovascular Therapy ANTARA(R) 130 mg (fenofibrate) Capsules From Reliant Pharmaceuticals
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 29 Jun 2006
Auxilium Pharmaceuticals Announces Start of U.S. Phase III Pivotal Trial of Testosterone Transmucosal Film (AA2600) for Hypogonadism
Biopharmaceuticals

HSMN NewsFeed - 28 Jun 2006
Oscient Pharmaceuticals Announces Meeting Date for FDA Advisory Committee to Address sNDA for Five-Day Treatment of Acute Bacterial Sinusitis with FACTIVE Tablets
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Jun 2006
Auxilium Appoints Armando Anido as Chief Executive Officer and President
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jun 2006
AEterna Zentaris Receives Green Light from FDA to Move Forward into Phase 3 Program with Cetrorelix in BPH
Biopharmaceuticals Urology FDA

HSMN NewsFeed - 21 Jun 2006
Auxilium Pharmaceuticals Announces Top-Line Results from a Pivotal Efficacy Study of AA4500 in Dupuytren's Disease and Revises 2006 Financial Guidance
Biopharmaceuticals

HSMN NewsFeed - 19 Jun 2006
ROZEREM(TM) (ramelteon) Shown to Be Effective in a First-Night-Effect Model of Transient Insomnia With No Evidence of Next-Day Residual Effects
Biopharmaceuticals

HSMN NewsFeed - 15 Jun 2006
Auxilium Pharmaceuticals Announces Top-Line Results From Phase IV Trial of Testim(R) in Patients With Type II Diabetes
Biopharmaceuticals

HSMN NewsFeed - 12 Jun 2006
Data Presented at American Diabetes Association Annual Meeting Suggest Testosterone Levels Correlate with Insulin Resistance and Insulin Sensitivity in Type 2 Diabetes Patients
Biopharmaceuticals

HSMN NewsFeed - 23 May 2006
Auxilium Pharmaceuticals Receives Approval to Sell Testim(R) in Canada
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 May 2006
Oscient Pharmaceuticals Hires Philippe M. Maitre as Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 May 2006
Repros Therapeutics Provides Update for Ongoing Clinical Studies
Biopharmaceuticals

HSMN NewsFeed - 19 May 2006
Esprit Pharma Acquires Exclusive North American Rights to a Novel Treatment for Hypoactive Sexual Desire Disorder in Women from Novavax
Biopharmaceuticals Licensing

HSMN NewsFeed - 19 May 2006
Novavax and Esprit Pharma to Co-develop Novel Medicine for Female Sexual Desire Disorder
Biopharmaceuticals Licensing

HSMN NewsFeed - 16 May 2006
Manhattan Pharmaceuticals Receives SwissMedic's Approval to Commence Phase IIa Trial With OE, Its Oral Obesity Drug Candidate
Biopharmaceuticals

HSMN NewsFeed - 10 May 2006
VIVUS Announces Positive Phase 2 Clinical Trial Results With Qnexa, a Novel Therapy to Treat Obesity
Biopharmaceuticals

HSMN NewsFeed - 5 May 2006
VIVUS Announces Positive Phase 3 Clinical Trial Results for Evamist(TM) - The First Transdermal Spray for the Treatment of Menopausal Symptoms
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 2 May 2006
Zonagen Effects Name Change to Repros Therapeutics Inc.
Biopharmaceuticals

HSMN NewsFeed - 20 Apr 2006
AEterna Zentaris Gains Market Approval for Cetrotide(R) (cetrorelix) in Japan for In Vitro Fertilization
Biopharmaceuticals Regulatory

HSMN NewsFeed - 19 Apr 2006
BioSante Pharmaceuticals Announces FDA Filing and Review of NDA for Bio-E-Gel(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Apr 2006
ROZEREM(TM) (ramelteon) Showed Significant Reduction in Time to Fall Asleep With No Evidence of Rebound Insomnia or Withdrawal Effects
Biopharmaceuticals

HSMN NewsFeed - 10 Mar 2006
BioSante Pharmaceuticals Presents Bio-E-Gel(TM) Data at The International Society for the Study of Women's Sexual Health Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 9 Mar 2006
Indevus Announces FDA Acceptance of IND for NEBIDO(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Mar 2006
Robert S. Mills Elected Chief Executive Officer of Columbia Laboratories
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Feb 2006
BioSante Pharmaceuticals Comments on New Data from Women's Health Initiative Study Showing No Increased Coronary Heart Risk with Estrogen-Alone Therapy
Biopharmaceuticals Cardiology

HSMN NewsFeed - 16 Feb 2006
BioSante Pharmaceuticals Announces Bio-E-Gel(TM) NDA Submission
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 8 Feb 2006
Oscient Pharmaceuticals Acquires Expanded Worldwide Rights to Lead Clinical Candidate Ramoplanin
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Feb 2006
Oscient Pharmaceuticals and Pfizer Enter Agreement for FACTIVE Tablets in Mexico
Biopharmaceuticals Licensing

HSMN NewsFeed - 3 Feb 2006
Zonagen Announces Positive Top-Line Results of Androxal(TM) Study
Biopharmaceuticals

HSMN NewsFeed - 1 Feb 2006
Cellegy Announces Licensing Agreement With CONRAD and Other Events
Biopharmaceuticals Licensing

HSMN NewsFeed - 30 Jan 2006
AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights for Cetrorelix in Benign Prostate Hyperplasia
Biopharmaceuticals Urology

HSMN NewsFeed - 24 Jan 2006
Serono's Gonal-f(R) Approved in Japan for the Treatment of Male Hypogonadotropic Hypogonadism
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Jan 2006
FDA Accepts for Filing Oscient Pharmaceuticals' Supplemental New Drug Application for Five-Day Treatment of CAP with FACTIVE(R) Tablets, Refuses Filing for Five-Day Treatment of ABS
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jan 2006
Cellegy Renegotiates Tostrex(R) EU License and Distribution Agreement With ProStrakan Group plc
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Jan 2006
Indevus Announces Closing of Delatestryl(R) Transaction
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 9 Jan 2006
Cellegy Reports Cellegesic to Be Reviewed by the Cardio-Renal Advisory Committee in April 2006
Biopharmaceuticals

HSMN NewsFeed - 9 Jan 2006
BioSante Pharmaceuticals Strengthens Management and Reaffirms Bio-E-Gel(TM) NDA Filing Guidance
Biopharmaceuticals

HSMN NewsFeed - 9 Jan 2006
Columbia Laboratories Announces Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jan 2006
Zonagen Receives IRB Approval to Commence Phase III Study of Androxal(TM) for the Treatment of Testosterone Deficiency
Biopharmaceuticals

Return to NewsFeed

Additional items found! 199

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 199 additional stories matching:
Testosterone
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.